Lazard US Equity Concentrated Portfolio (RLUEX) Stock Analysis
DELISTED 2026
What happened to Lazard US Equity Concentrated Portfolio (RLUEX) stock?
Lazard US Equity Concentrated Portfolio (RLUEX) no longer trades on public markets. It was delisted in May 2026. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Lazard US Equity Concentrated Portfolio (RLUEX) trades at $15.59. Lazard US Equity Concentrated Portfolio (RLUEX) is a non-diversified mutual fund focused on concentrated investments in U. S. equities, aiming for long-term capital appreciation. Market cap: $1.53B, Sector: Financial services.
Last analyzed: Jun 15, 2026Analyst Coverage for RLUEX: RLUEX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RLUEX against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
RLUEX: the 2 scored disciplines are evenly split. Dominant signal: Izzy Englander bullish.
How is this calculated? →Lazard US Equity Concentrated Portfolio (RLUEX) Financial Services Profile
Lazard US Equity Concentrated Portfolio (RLUEX) is a non-diversified mutual fund specializing in concentrated investments within U.S. equities. It targets 15-35 companies, typically exceeding $350 million in market capitalization, aiming for superior returns against benchmarks like the S&P 500®. The fund allocates at least 80% of its capital to U.S. equity investments.
What Is the Investment Thesis for RLUEX?
The Lazard US Equity Concentrated Portfolio (RLUEX) presents an investment thesis centered on its active, concentrated strategy within U.S. equities, aiming for long-term capital appreciation. With a market capitalization of $1.53B, the fund's objective is to achieve returns superior to benchmarks such as the S&P 500®, Russell 1000®, and Russell 3000® Indices. This goal is pursued through a portfolio typically holding 15 to 35 enterprises, primarily those with market valuations exceeding $350 million, and allocating at least 80% of its capital to U.S.-based companies. The fund's non-diversified nature, while potentially leading to higher volatility (evidenced by a Beta of 1.18), also offers the potential for significant outperformance if its concentrated bets prove successful. The experienced management team, as highlighted by AI insights, is a key value driver, tasked with identifying high-conviction investment opportunities. The absence of a dividend yield further emphasizes the fund's focus on capital growth. Investors considering RLUEX are implicitly seeking a higher risk-reward profile, banking on the fund's ability to leverage its focused approach to generate alpha in the dynamic U.S. equity market.
Based on FMP financials and quantitative analysis
RLUEX Key Highlights
Market Capitalization: $1.53 billion, positioning it as a significant, albeit specialized, player within the mutual fund landscape.
- Beta: 1.18, indicating that the fund's price movements tend to be more volatile than the overall market.
- Dividend Yield: None, signifying a primary investment objective focused on capital appreciation rather than income generation.
- Concentrated Holdings: Typically consists of 15 to 35 enterprises, highlighting its high-conviction, non-diversified investment strategy.
- U.S. Equity Allocation: A minimum of 80% of its capital is allocated to equity investments in U.S.-based companies, defining its core geographic and asset class focus.
Who Are RLUEX's Competitors?
RLUEX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CET Central Securities Corp. | $54.21 | -0.90% | $1.60B | 70 |
| HQH Abrdn Healthcare Investors | $23.84 | -3.33% | $1.36B | 71 |
| TSLX Sixth Street Specialty Lending, Inc. | $18.77 | +0.37% | $1.78B | 68 |
| ASA ASA Gold and Precious Metals Limited | $62.31 | +0.10% | $1.17B | 70 |
| AOD Abrdn Total Dynamic Dividend Fund | $10.68 | +0.56% | $1.13B | 68 |
| GSBD Goldman Sachs BDC, Inc. | $9.92 | +0.40% | $1.12B | 91 |
| FSCO FS Credit Opportunities Corp. | $5.14 | -0.58% | $1.04B | 93 |
| MUC BlackRock MuniHoldings California Quality Fund, Inc. | $10.60 | -0.75% | $998M | 67 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RLUEX's Key Strengths?
Experienced management team capable of executing a high-conviction, concentrated investment strategy.
- Potential for significant alpha generation due to its focused approach on a select number of U.S. equities.
- Clear objective to outperform major market benchmarks, appealing to performance-driven investors.
- Strong commitment to U.S. equities, leveraging the depth and breadth of the American market.
What Are RLUEX's Weaknesses?
Higher volatility compared to diversified funds due to its non-diversified and concentrated portfolio structure (Beta of 1.18).
- Significant reliance on the performance of a limited number of holdings, increasing specific stock risk.
- Potential for underperformance if concentrated bets do not materialize as expected, leading to significant drawdowns.
- May not appeal to risk-averse investors seeking broad market exposure and lower volatility.
What Could Drive RLUEX Stock Higher?
RLUEX catalyst: Strong performance of key portfolio holdings, driving overall fund returns and potentially attracting new investor capital.
- Sustained outperformance against its stated benchmarks, including the S&P 500® and Russell 1000® Indices, validating its active management strategy.
- Favorable U.S. economic data and corporate earnings reports that bolster investor confidence in the fund's underlying equity universe.
- Positive shifts in investor sentiment towards active, concentrated investment strategies, leading to increased demand for RLUEX.
- Successful identification and investment in emerging growth companies within the U.S. market that significantly contribute to portfolio alpha.
What Are the Key Risks for RLUEX?
Higher volatility inherent in its non-diversified, concentrated portfolio, which can lead to more significant price fluctuations than broader market funds.
- Underperformance of a few key holdings, given the fund's concentrated nature, could disproportionately impact overall fund returns and investor confidence.
- Sustained market downturns or prolonged periods of underperformance in U.S. equities, which form at least 80% of the fund's capital allocation.
- Increased investor preference for lower-cost passive investment vehicles, potentially leading to reduced demand and outflows from actively managed funds like RLUEX.
- Regulatory changes impacting mutual fund operations, investment restrictions, or fee structures, which could affect the fund's profitability or operational flexibility.
What Are the Growth Opportunities for RLUEX?
- Outperformance through Active Management: The fund's concentrated strategy, coupled with an experienced management team, presents a significant opportunity to generate alpha by identifying undervalued U.S. equities. By focusing on 15 to 35 high-conviction holdings, the fund aims to capitalize on specific company fundamentals and market inefficiencies that broader, more diversified funds might overlook. This active approach, if successful in consistently outperforming its S&P 500® and Russell 1000® benchmarks, could attract substantial inflows from institutional and individual investors seeking specialized expertise and superior returns in the U.S. equity market.
- Increased Demand for Concentrated Portfolios: As investors become more sophisticated and seek differentiated strategies, there is a growing segment interested in concentrated portfolios. These investors are often willing to accept higher volatility in exchange for the potential of higher returns that a focused approach can offer. RLUEX is well-positioned to capture this demand, particularly from those who believe in the ability of skilled managers to identify and commit capital to a select group of high-quality companies, rather than simply tracking a broad market index. This niche market could expand as investors seek to diversify their overall portfolio risk by adding focused, actively managed components.
- Expansion of U.S. Equity Market: The continued robust growth and innovation within the U.S. economy provide a fertile and expanding universe for RLUEX's investment strategy. As U.S. companies across various sectors continue to grow, innovate, and expand their market reach, the fund has a broad pool of potential investments that meet its criteria of market capitalization exceeding $350 million. This ongoing economic expansion and corporate earnings growth offer a foundational tailwind for the fund's holdings, increasing the likelihood of capital appreciation over the long term, assuming sound stock selection by the management team.
- Attracting Institutional Investors: The fund's explicit objective of achieving returns superior to prominent market benchmarks like the S&P 500®, Russell 1000®, and Russell 3000® Indices makes it a potentially noteworthy option for institutional investors. Pension funds, endowments, and other large asset allocators often seek specialized mandates and active managers who can demonstrate a clear strategy for alpha generation. RLUEX's concentrated, U.S.-focused approach could fit into a broader institutional portfolio as a high-conviction component, drawing significant capital inflows if its performance track record consistently meets or exceeds its stated objectives.
- Leveraging Market Volatility: A concentrated portfolio, while inherently more volatile (Beta of 1.18), can also be more agile in capitalizing on market dislocations or specific sector trends. In periods of heightened market volatility or significant shifts in economic cycles, a fund with fewer holdings can potentially make more decisive moves, either by increasing exposure to favored companies or by reducing positions in those facing headwinds. This agility, when executed effectively by an experienced management team, could enable RLUEX to generate outsized returns during periods where broadly diversified funds might struggle to adapt quickly, offering a distinct advantage in dynamic market conditions.
What Are RLUEX's Competitive Advantages?
- Experienced Management Team: The fund benefits from an experienced management team, crucial for its active, concentrated investment strategy.
- Specialized Investment Strategy: Its non-diversified, concentrated approach to U.S. equities offers a distinct value proposition not found in broad market funds.
- Research Capabilities: As part of Lazard, the fund likely leverages extensive research and analytical capabilities to identify high-conviction investment opportunities.
- Brand Reputation: Association with Lazard, an established financial services firm, lends credibility and trust in the asset management space.
What Does RLUEX Do?
The Lazard US Equity Concentrated Portfolio (RLUEX) operates as a mutual fund within the asset management sector, headquartered in New York, US. Its core mandate is to acquire common stock in American companies, distinguishing itself through a highly concentrated investment strategy. While the fund possesses the flexibility to invest across the entire spectrum of market capitalizations, its portfolio typically comprises a focused selection of 15 to 35 enterprises. A significant preference is given to companies with market valuations generally exceeding $350 million, indicating a focus on established, mid-to-large capitalization entities within the U.S. market. The primary objective of RLUEX is to achieve investment returns that are superior to those of prominent market benchmarks, including the S&P 500®, Russell 1000®, and Russell 3000® Indices. This ambition underscores its active management approach, where the fund managers aim to generate alpha through selective stock picking rather than simply tracking an index. Under normal operating conditions, the portfolio maintains a substantial commitment to U.S.-based equity investments, allocating a minimum of 80% of its total capital to this asset class. This strategic allocation reinforces its dedication to the American equity market. A key characteristic of RLUEX, as explicitly stated, is its classification as a non-diversified fund. This means that a relatively large portion of its assets may be invested in a smaller number of issuers, leading to a higher degree of concentration risk compared to more broadly diversified funds. The fund's market position is thus defined by its concentrated strategy, which differentiates it from many broader market funds by focusing on a select group of companies believed to offer significant growth potential. The fund's evolution reflects a strategic choice to pursue potentially higher returns through conviction-based investing, accepting the inherent volatility that comes with a less diversified portfolio.
What Products and Services Does RLUEX Offer?
- Primarily acquires common stock in American companies.
- Maintains concentrated holdings, typically consisting of 15 to 35 enterprises.
- Generally favors companies with market valuations exceeding $350 million.
- Aims to achieve returns superior to benchmarks like the S&P 500®, Russell 1000®, and Russell 3000® Indices.
- Allocates a minimum of 80% of its capital to equity investments in U.S.-based companies under normal operating conditions.
- Operates as a non-diversified fund, meaning a significant portion of assets may be invested in a limited number of issuers.
- Focuses on long-term capital appreciation for its investors.
How Does RLUEX Make Money?
- Generates revenue primarily through management fees charged on assets under management (AUM).
- Aims to increase its AUM through strong investment performance and attracting new capital from investors.
- Profits from the capital appreciation of its underlying equity holdings, which contributes to fund growth and investor returns.
What Industry Does RLUEX Operate In?
The Lazard US Equity Concentrated Portfolio operates within the highly competitive and dynamic asset management industry, a segment of the broader financial services sector. This industry is characterized by ongoing trends such as the shift between active and passive investment strategies, evolving regulatory landscapes, and increasing investor demand for transparency and performance. RLUEX positions itself firmly within the active management segment, specifically targeting investors seeking concentrated exposure to U.S. equities. Its objective to achieve returns superior to major benchmarks like the S&P 500® and Russell 1000® places it in direct competition with a multitude of actively managed funds, as well as lower-cost index funds and ETFs. The fund's non-diversified nature is a key differentiator, appealing to a niche segment of investors willing to accept higher volatility for the potential of greater alpha generation through high-conviction stock picking. The broader market trend sees continued growth in U.S. equities, providing a fertile ground for the fund's investment universe, but also intensifying the competition for investor capital.
Who Are RLUEX's Key Customers?
- Individual investors seeking active management and concentrated U.S. equity exposure.
- Institutional investors, such as pension funds, endowments, and foundations, looking for specialized mandates.
- Financial advisors and wealth managers allocating client capital to actively managed funds.
- Retirement plans and other long-term investment vehicles.
Lazard US Equity Concentrated Portfolio (RLUEX) Valuation Context
Valued at $1.53B, RLUEX is classified as a small-cap stock.
Key Financial Metrics
Return on equity for Lazard US Equity Concentrated Portfolio stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. RLUEX trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
RLUEX Financials
Bull Case vs Bear Case
Bull Case
- Experienced management team capable of executing a high-conviction, concentrated investment strategy.
- Potential for significant alpha generation due to its focused approach on a select number of U.S. equities.
- Clear objective to outperform major market benchmarks, appealing to performance-driven investors.
- Strong commitment to U.S. equities, leveraging the depth and breadth of the American market.
Bear Case
- Higher volatility compared to diversified funds due to its non-diversified and concentrated portfolio structure (Beta of 1.18).
- Significant reliance on the performance of a limited number of holdings, increasing specific stock risk.
- Potential for underperformance if concentrated bets do not materialize as expected, leading to significant drawdowns.
- May not appeal to risk-averse investors seeking broad market exposure and lower volatility.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
RLUEX Latest News
No recent news available for RLUEX.
Common Questions About RLUEX (Financial Services)
What happened to Lazard US Equity Concentrated Portfolio (RLUEX) stock?
Lazard US Equity Concentrated Portfolio (RLUEX) no longer trades on public markets. It was delisted in May 2026. The figures below are historical and are not a current quote.
Can I still buy RLUEX shares?
No. RLUEX stopped trading on public markets in May 2026, so the shares are not available through a broker. Anything you see quoted for RLUEX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before RLUEX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Lazard US Equity Concentrated Portfolio. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What is the investment strategy of the Lazard US Equity Concentrated Portfolio?
The Lazard US Equity Concentrated Portfolio (RLUEX) employs a highly focused investment strategy centered on U.S. equities. The fund's primary objective is to acquire common stock in American companies, with a strong preference for those exceeding $350 million in market capitalization. Its portfolio is notably concentrated, typically holding between 15 and 35 enterprises.
How does the Lazard US Equity Concentrated Portfolio aim to generate returns?
The Lazard US Equity Concentrated Portfolio (RLUEX) aims to generate returns primarily through long-term capital appreciation of its underlying equity holdings. Its strategy is to identify and invest in a concentrated selection of 15 to 35 U.S. companies, predominantly those with market capitalizations above $350 million, that are believed to have strong growth potential or are undervalued.
What are the key risks associated with investing in RLUEX?
Investing in the Lazard US Equity Concentrated Portfolio (RLUEX) carries several key risks, primarily stemming from its non-diversified and concentrated investment strategy. The fund's Beta of 1.18 indicates higher volatility compared to the broader market, meaning its value can fluctuate more significantly.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based solely on provided source data. No external research or market data was used.